A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men
Status:
Completed
Trial end date:
2016-04-17
Target enrollment:
Participant gender:
Summary
This is a randomized, single-blind, placebo-controlled, sequential-group study to assess the
safety and tolerability as well as how the drug (AZD7594) affects the body (pharmacodynamics
[PD]) and how the body affects the drug (pharmacokinetics [PK]) when AZD7594 is given as
single and multiple ascending doses once daily by inhalation to healthy male Japanese
subjects, compared with placebo (non-active drug)